Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Cantargia

4.02 SEK

+0.25 %

1,287 following

CANTA

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Cantargia

P/E

Median 2019-2025

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)16.7753.2615.363.083.741.694.19
Shares87.5120.4120.4167.0183.7183.7248.6
Market cap1,467.06,412.31,849.6514.3686.6310.41,040.4
Enterprise value1,317.15,508.91,290.287.7491.9277.4-
EV/S-------
EV/EBITDAneg.neg.neg.neg.neg.neg.-
EV/EBITneg.neg.neg.neg.neg.neg.-
P/Eneg.neg.neg.neg.neg.neg.7.1
P/B10.317.193.471.324.072.673.91
P/S------3.3
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio85.7 %96.4 %88.8 %82.1 %75.4 %68.2 %89.6 %
Gearing ratio-------
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.